No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CCNE CNB Financial
- 19.460
- +0.180+0.93%
Close Jun 18 16:00 ET
- 19.460
- 0.0000.00%
Post 16:18 ET
408.73MMarket Cap8.21P/E (TTM)
19.620High19.400Low30.32KVolume19.490Open19.280Pre Close590.80KTurnover0.15%Turnover Ratio7.63P/E (Static)21.00MShares22.98152wk High0.78P/B395.15MFloat Cap16.60052wk Low0.70Dividend TTM20.31MShs Float29.200Historical High3.60%Div YieldTTM1.14%Amplitude2.419Historical Low19.488Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Why You Might Be Interested In CNB Financial Corporation (NASDAQ:CCNE) For Its Upcoming Dividend
CNB Financial To Go Ex-Dividend On May 31st, 2024 With 0.175 USD Dividend Per Share
May 16th - $CNB Financial(CCNE.US)$ is trading ex-dividend on May 31st, 2024. Shareholders of record on May 31st, 2024 will receive 0.175 USD dividend per share on June 14th, 2024. The ex-dividend
Express News | CNB Financial Declares $0.175 Quarterly Dividend
Express News | CNB Financial Corporation Announces Quarterly Dividend for Common Stock
Press Release: CNB Financial Corporation Announces Quarterly Dividend For Series A Preferred Stock and Related Depositary Shares Distribution
CNB Financial Corporation Announces Quarterly Dividend For Series A Preferred Stock and Related Depositary Shares Distribution CLEARFIELD, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- The Board of Directors
CNB Financial Corporation (NASDAQ:CCNE) Is Largely Controlled by Institutional Shareholders Who Own 56% of the Company
Comments
Gapping up
In reaction to earnings/guidance:
• $Bowlero(BOWL.US$ +3.4%
Other news:
• $Intellia Therapeutics(NTLA.US$ +10.8% (Interim Clinical Data for its Second Systemically Delivered Investigational CRISPR Candidate, NTLA-2002)
• $Gogo Inc(GOGO.US$ +5% (Repurchases 1.5 million shares of common stock from BlackRock)
• $ADC Therapeutics(ADCT.US$ +2.9% (ADC Therapeutics and Swedish Orphan Biovitrum AB (BIOVF) confirms positive CHM...
In reaction to earnings/guidance:
• $Bowlero(BOWL.US$ +3.4%
Other news:
• $Intellia Therapeutics(NTLA.US$ +10.8% (Interim Clinical Data for its Second Systemically Delivered Investigational CRISPR Candidate, NTLA-2002)
• $Gogo Inc(GOGO.US$ +5% (Repurchases 1.5 million shares of common stock from BlackRock)
• $ADC Therapeutics(ADCT.US$ +2.9% (ADC Therapeutics and Swedish Orphan Biovitrum AB (BIOVF) confirms positive CHM...
13
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg